Kennen Mac Kay

BBioMarin’s Study of Its Hemophilia Gene-Therapy Looked Good barrons.com
BRegeneron Signs Up Roche to Help Manufacture Covid-19 Antibody barrons.com
Phase 2 , United States
BRegeneron Jumps After Earnings Beat Expectations barrons.com
Stock Island
BBioMarin Stock Jumps as Analyst Calls Doubts Over Hemophilia Drug ‘Overblown’barrons.com
Phase 2
BAlexion CFO Is Unexpectedly Leaving barrons.com
Europe
BAmgen Paid Too Much for Otezla. Why One Analyst Says It Was the Right Thing to Do.barrons.com
BAmgen's Earnings Weren't a Thrill, but Promising Cancer-Drug Results Are Lifting the Stock barrons.com
Phase 2 , Wall Street
MLawsuit over migraine deal could be good for Amgen, analysts say marketwatch.com
Wall Street , Japan
MIn 'high risk gambit,' Amgen slashes price of underused cholesterol drug marketwatch.com
MProthena shares plummet 60% on discontinued drug marketwatch.com

Frequent names

Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.